{"organizations": [], "uuid": "7afcc49a57d3c099a9924849b14df7ecf05ca138", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000027/page/12", "section_title": "Press Releases - CNBC", "url": "http://www.cnbc.com/2018/05/01/business-wire-gilead-sciences-announces-second-quarter-2018-dividend.html", "country": "US", "domain_rank": 767, "title": "Gilead Sciences Announces Second Quarter 2018 Dividend", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.001, "site_type": "news", "published": "2018-05-02T00:02:00.000+03:00", "replies_count": 0, "uuid": "7afcc49a57d3c099a9924849b14df7ecf05ca138"}, "author": "cnbc.com", "url": "http://www.cnbc.com/2018/05/01/business-wire-gilead-sciences-announces-second-quarter-2018-dividend.html", "ord_in_thread": 0, "title": "Gilead Sciences Announces Second Quarter 2018 Dividend", "locations": [], "entities": {"persons": [{"name": "robin wash", "sentiment": "none"}], "locations": [{"name": "foster city", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "foster city", "sentiment": "none"}, {"name": "california", "sentiment": "none"}], "organizations": [{"name": "gilead sciences", "sentiment": "negative"}, {"name": "gilead sciences, inc.", "sentiment": "neutral"}, {"name": "gilead gilead sciences", "sentiment": "none"}, {"name": "board", "sentiment": "none"}, {"name": "gilead", "sentiment": "none"}, {"name": "gilead public affairs", "sentiment": "none"}, {"name": "gilead sciences, inc", "sentiment": "none"}, {"name": "board of directors", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company’s Board of Directors has declared a cash dividend of $0.57 per share of common stock for the second quarter of 2018. The dividend is payable on June 28, 2018, to stockholders of record at the close of business on June 15, 2018. Future dividends will be subject to Board approval.\nAbout Gilead\nGilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.\nFor more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.\nView source version on businesswire.com : https://www.businesswire.com/news/home/20180501006178/en/\nInvestors\nGilead Sciences, Inc.\nRobin Washington, 650-522-5688\nSung Lee, 650-524-7792\nSource: Gilead Sciences, Inc.", "external_links": ["https://www.businesswire.com/news/home/20180501006178/en/", "http://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.gilead.com&esheet=51798805&newsitemid=20180501006178&lan=en-US&anchor=www.gilead.com&index=1&md5=d4d04a1d856a32b548a3a82d642ee597"], "published": "2018-05-02T00:02:00.000+03:00", "crawled": "2018-05-02T02:55:53.020+03:00", "highlightTitle": ""}